News and Views
Nature Biotechnology 26, 769 - 770 (2008)
doi:10.1038/nbt0708-769
Hitting the mother lode of tumor angiogenesis
Daylon James1, Sina Rabbany1 & Shahin Rafii1
-
Daylon James, Sina Rabbany and Shahin Rafii are in the Howard Hughes Medical Institute and the Department of Genetic Medicine of the Weill Cornell Medical College, 1300 York Avenue, Rm. A-863, New York, New York 10021, USA.
e-mail: srafii@med.cornell.edu
Abstract
An oral formulation of an antiangiogenic drug may allow long-term anti-cancer therapy.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
An orally delivered small-molecule formulation with antiangiogenic and anticancer activityNature Biotechnology Research (01 Jul 2008)
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470Nature Medicine Article (01 Mar 2004)
